Richard Newitter

Q: How accurate are Richard Newitter's stock ratings?

About 58% of Richard's ratings were profitable over a one-year hold, with an average return of +5.9% per rating, measured by 13Foresight from historical prices.

Q: How is Richard ranked?

Richard Newitter is ranked #911 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Truist Financial

Wall Street Analyst

★★★★☆

#911

on 13Foresight · ranked by our own returns

58%

Success Rate

+5.9%

Average Return

56 of 97 calls profitable · +3.0% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compared To ⓘ

S&P 500 (SPY)

📈 Across the calls we could measure, roughly 58% of Richard Newitter's ratings turned a profit when each position was held for 1 year — averaging +5.9% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

143 Buy 82 Hold 0 Sell

Richard's Stock Coverage 46 ratings · 2026-08-08

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return	vs S&P 500 ⓘ
TNDM Tandem Diabetes Care	Aug 07, 2026	BUY	Buy +49.4% avg upside 29 analysts	$31.00 64.89% Upside	·	·
GMED Globus Medical	Aug 07, 2026	BUY	Strong Buy +13.1% avg upside 24 analysts	$100.00 23.38% Upside	+0.0%	·
ZBH Zimmer Biomet Holdings	Aug 07, 2026	HOLD	Buy +17.4% avg upside 38 analysts	$106.00 9.00% Upside	+0.0%	·
CARL Carlsmed, Inc.	Aug 06, 2026	BUY	Strong Buy +36.2% avg upside 6 analysts	$20.00 45.89% Upside	·	·
PODD Insulet	Aug 06, 2026	HOLD	Strong Buy +54.3% avg upside 32 analysts	$153.00 9.85% Upside	+0.0%	·
PRCT PROCEPT BioRobotics	Aug 05, 2026	HOLD	Buy +56.7% avg upside 17 analysts	$21.00 4.89% Upside	+3.6%	·
LNTH Lantheus	Aug 04, 2026	HOLD	Buy -18.4% avg upside 21 analysts	$102.50 1.34% Upside	-0.1%	·
SIBN SI-Bone	Aug 04, 2026	BUY	Strong Buy +40.9% avg upside 18 analysts	$23.00 26.73% Upside	+0.0%	·
INSP Inspire Medical Systems	Aug 04, 2026	HOLD	Buy +41.6% avg upside 21 analysts	$62.00 5.24% Upside	·	·
ITGR Integer Holdings	Aug 04, 2026	HOLD	Buy -18.3% avg upside 16 analysts	$127.00 0.65% Upside	+0.2%	·
DXCM Dexcom	Jul 31, 2026	BUY	Strong Buy +24.0% avg upside 32 analysts	$93.00 12.08% Upside	+1.6%	·
SYK Stryker	Jul 31, 2026	HOLD	Strong Buy +8.8% avg upside 37 analysts	$340.00 0.82% Upside	+4.1%	·
VCEL Vericel	Jul 31, 2026	BUY	Strong Buy +5.5% avg upside 16 analysts	$58.00 29.57% Upside	-1.9%	·
GKOS Glaukos	Jul 30, 2026	BUY	Strong Buy -7.1% avg upside 21 analysts	$215.00 25.69% Upside	+4.9%	·
BBNX Beta Bionics, Inc.	Jul 30, 2026	BUY	Strong Buy +35.1% avg upside 13 analysts	$22.00 55.83% Upside	-10.1%	·
BSX Boston Scientific	Jul 30, 2026	BUY	Strong Buy +37.4% avg upside 38 analysts	$57.00 15.58% Upside	+7.2%	·
EW Edwards Lifesciences	Jul 24, 2026	HOLD	Strong Buy +12.1% avg upside 34 analysts	$95.00 6.42% Upside	+8.6%	·
ISRG Intuitive Surgical	Jul 17, 2026	BUY	Strong Buy +26.9% avg upside 36 analysts	$510.00 36.41% Upside	+9.7%	·
IRTC Irhythm Technologies	Jul 16, 2026	BUY	Strong Buy +27.9% avg upside 20 analysts	$160.00 24.82% Upside	+11.1%	·
TMCI Treace Medical Concepts	Jul 16, 2026	HOLD	Hold +20.0% avg upside 8 analysts	$4.00 8.68% Downside	+7.4%	·
MDT Medtronic	Jun 04, 2026	HOLD	Buy +10.9% avg upside 38 analysts	$86.00 0.13% Upside	+7.3%	·
KIDS OrthoPediatrics	Mar 02, 2026	HOLD	Strong Buy +37.2% avg upside 10 analysts	$20.00 12.39% Downside	+18.5%	·
TFX Teleflex	Feb 27, 2026	HOLD	Buy +38.0% avg upside 20 analysts	—	-2.4%	·
MBX MBX Biosciences, Inc.	Jan 16, 2026	BUY	Strong Buy +14.0% avg upside 14 analysts	—	+67.3%	·
PEN Penumbra	Jan 16, 2026	HOLD	Buy +1.8% avg upside 23 analysts	$374.00 15.08% Upside	-7.4%	·
IART Integra Lifesciences	Dec 23, 2025	HOLD	Buy +151.8% avg upside 21 analysts	$13.00 24.03% Downside	-12.4%	·
KYMR Kymera Therapeutics	Jun 26, 2025	BUY	Strong Buy -2.1% avg upside 37 analysts	—	+136.5%	·
RXO RXO, Inc.	Jun 18, 2025	BUY	Buy +8.8% avg upside 26 analysts	—	+64.2%	·
JAZZ Jazz Pharmaceuticals	Oct 16, 2024	BUY	Strong Buy -7.8% avg upside 35 analysts	—	+16.1%	·
KROS Keros Therapeutics	Jun 20, 2024	BUY	Strong Buy +117.5% avg upside 21 analysts	—	-70.3%	·
PGNY Progyny	Apr 17, 2024	BUY	Strong Buy +15.7% avg upside 14 analysts	—	-34.5%	·
MMM 3M	Aug 22, 2023	HOLD	Buy -7.3% avg upside 24 analysts	$148.00 18.16% Downside	+62.4%	·
ORGO Organogenesis Holdings	Oct 07, 2021	BUY	Strong Buy +531.6% avg upside 8 analysts	—	-74.4%	·
RXST RxSight	Sep 10, 2021	BUY	Hold +40.7% avg upside 13 analysts	$20.00 229.01% Upside	+5.3%	·
CH:ALC Alcon	Aug 17, 2021	HOLD	Buy +24.2% avg upside 35 analysts	$66.11 15.82% Upside	-10.1%	·
A Agilent	Aug 06, 2021	BUY	Strong Buy +2.3% avg upside 33 analysts	—	-13.7%	·
AXGN AxoGen	Aug 05, 2021	BUY	Strong Buy -23.0% avg upside 21 analysts	$27.00 39.10% Downside	-45.5%	·
LNSR LENSAR	Aug 05, 2021	BUY	Strong Buy +108.0% avg upside 4 analysts	$20.00 248.76% Upside	-24.4%	·
BDX Becton Dickinson	Aug 05, 2021	HOLD	Buy +10.3% avg upside 25 analysts	$250.00 41.14% Upside	+8.6%	·
CNMD Conmed	Jul 28, 2021	HOLD	Hold +31.9% avg upside 12 analysts	$141.00 183.33% Upside	-27.9%	·
ALGN Align Tech	Jul 28, 2021	BUY	Strong Buy +72.2% avg upside 21 analysts	$770.00 355.47% Upside	-54.6%	·
ATRC Atricure	Jul 15, 2016	BUY	Strong Buy +12.7% avg upside 13 analysts	$20.00 49.39% Downside	+59.5%	·
SENS Senseonics Holdings	Jul 15, 2016	BUY	Buy +120.3% avg upside 13 analysts	$4.50 12.59% Downside	-41.3%	·
JNJ Johnson & Johnson	Jul 15, 2016	BUY	Strong Buy -8.8% avg upside 39 analysts	$140.00 45.54% Downside	+10.7%	·
BAX Baxter International	Jul 15, 2016	HOLD	Buy +21.8% avg upside 23 analysts	$47.00 74.05% Upside	+34.3%	·
ABT Abbott Laboratories	Jul 15, 2016	HOLD	Strong Buy +6.9% avg upside 36 analysts	$45.00 58.24% Downside	+19.0%	·

🔒 41 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Richard Newitter — Frequently Asked Questions

How accurate are Richard Newitter's stock ratings?

Based on the calls 13Foresight could measure, about 58% of Richard's ratings were profitable over a one-year hold, with an average return of +5.9% per rating, or +3.0% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.

How is Richard ranked on 13Foresight?

Richard Newitter is currently ranked #911 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Richard cover?

Richard most recently has ratings on TNDM, GMED, ZBH, CARL, PODD, PRCT, LNTH, SIBN, INSP, ITGR, DXCM, SYK and 34 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Richard Newitter

Rating Distribution

Welcome to 13Foresight!